SRF expects better Q4 for specialty chemicals biz. But is that enough?
SRF Ltd’s shares fell 8% in the past two trading sessions as weaker-than-anticipated December quarter (Q3FY26) results triggered earnings downgrades by various brokerages. Consolidated revenue at ₹3,713 crore missed consensus estimate of ₹3,800 crores. EBITDA at ₹780 crore was much lower than the consensus estimate of ₹820 crores. The problem is that SRF’s chemicals business…